Home / business / Lupin Shares Surge 7.7% After Launch of Generic Drug in US Market

Lupin Shares Surge 7.7% After Launch of Generic Drug in US Market

-
The new tablets — the generic version of Novartis Pharmaceuticals Corp’s Myfortic delayed-release tablets — are used to prevent organ rejection in patients receiving kidney transplants.

from Top Business News- News18.com
Read The Rest:timesnownews...
Lupin Shares Surge 7.7% After Launch of Generic Drug in US Market Lupin Shares Surge 7.7% After Launch of Generic Drug in US Market Reviewed by Team Exprssnews on April 07, 2020 Rating: 5

No comments:

Subscribe to: Post Comments ( Atom )
Powered by Blogger.